Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Change in Taxes (2016 - 2021)

Historic Change in Taxes for Fresenius Medical Care AG (FMCQF) over the last 12 years, with Q2 2021 value amounting to $169.2 million.

  • Fresenius Medical Care AG's Change in Taxes rose 12812.69% to $169.2 million in Q2 2021 from the same period last year, while for Jun 2021 it was $169.2 million, marking a year-over-year decrease of 4295.2%. This contributed to the annual value of $64.7 million for FY2020, which is 20374.99% up from last year.
  • As of Q2 2021, Fresenius Medical Care AG's Change in Taxes stood at $169.2 million, which was up 12812.69% from $175.0 million recorded in Q1 2021.
  • Over the past 5 years, Fresenius Medical Care AG's Change in Taxes peaked at $416.7 million during Q2 2017, and registered a low of $199470.8 during Q1 2017.
  • For the 5-year period, Fresenius Medical Care AG's Change in Taxes averaged around $131.1 million, with its median value being $127.5 million (2018).
  • As far as peak fluctuations go, Fresenius Medical Care AG's Change in Taxes crashed by 9941.91% in 2017, and later skyrocketed by 6057007.0% in 2018.
  • Quarter analysis of 5 years shows Fresenius Medical Care AG's Change in Taxes stood at $759286.3 in 2017, then decreased by 22.59% to $587770.1 in 2018, then soared by 4986.33% to $29.9 million in 2019, then skyrocketed by 372.15% to $141.2 million in 2020, then grew by 19.86% to $169.2 million in 2021.
  • Its Change in Taxes stands at $169.2 million for Q2 2021, versus $175.0 million for Q1 2021 and $141.2 million for Q4 2020.